Viridian Therapeutics, Inc. (VRDN) Misses Q4 EPS by 37c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q4 EPS of ($1.35), $0.37 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction
• This Is The Top REIT Stock Stifel Analysts Are Backing Right Now